Government Funded research Archives - Page 15 of 42

KEI Comments on NIH Exclusive License to Norwegian Firm Zelluna

Posted on April 15, 2021 by Claire Cassedy

(Update: The NIH provided a response to our comments on April 15, 2021.) On Wednesday April 14, 2021, Knowledge Ecology International (KEI) filed comments with the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License:… Continue Reading →

KEI Briefing Note 2021:3, The number of standard and material CRADAs executed by the NIH from 1985 to 2020 and the relationship to NIH reasonable pricing clause

The number of standard and material CRADAs executed by the NIH from 1985 to 2020 and the relationship to NIH reasonable pricing clause KEI Briefing Note 2021:3 James Love April 5, 2021 KEI-BN-2021-3

$1.3 Billion Johnson & Johnson COVID-19 Vaccine Development Contract Contains Broad Redactions Relating to Public’s Rights in Inventions

Posted on April 1, 2021 by Kathryn Ardizzone

On March 31, 2020, KEI received a copy of the contract between Johnson & Johnson (“J&J”) and the Department of Health and Human Services (HHS) for the development of J&J’s COVID-19 vaccine.The contract, which is now valued at $1.3 billion,… Continue Reading →

KEI Comments on NIH Exclusive License to Ridgeback for FDA-approved Ebola Treatment

Posted on March 31, 2021 by Claire Cassedy

(Update: On April 30, 2021, the NIH sent a response to KEI’s comments.) On March 30, 2021, Knowledge Ecology International (KEI) filed comments regarding the National Institute of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID), “Prospective Grant… Continue Reading →

KEI Briefing Note 2021:1 Comments on the Proposal to Eliminate Unreasonable Prices as a Standalone Basis for March-in Rights (Modify 37 CFR § 401.6)

Comments on the Proposal to Eliminate Unreasonable Prices as a Standalone Basis for March-in Rights (Modify 37 CFR § 401.6) KEI Briefing Note 2021:1 March 18, 2021 James Love (Note: The contents of this briefing note were submitted to the… Continue Reading →

License to NIH Spike Protein Technology Needed in COVID-19 Vaccines Demonstrates “Available to the Public on Reasonable Terms” Requirement

Posted on March 30, 2021 by Kathryn Ardizzone

A March 21, 2021 New York Times article on vaccine access discusses how a technology invented and owned by the National Institutes of Health (NIH) is necessary to make several COVID-19 vaccines. The invention mentioned by the Times, titled Prefusion… Continue Reading →

Kathryn Ardizzone, KEI Comment to NIST Regarding Proposal to Deny Members of the Public Standing to Appeal Government Licenses

Posted on March 26, 2021 by Kathryn Ardizzone

PDF version here: KA-KEI-NIST-Standing-26March2021 More on the NIST proposed changes to the Bayh-Dole Regulations: https://www.keionline.org/35432 Kathryn Ardizzone Counsel, Knowledge Ecology International National Institute of Standards and Technologies Rights to Federally Funded Inventions and Licensing of Government Owned Inventions Docket No.:… Continue Reading →

Luis Gil Abinader NIST comments on the definition of Subject Invention, 26 March 2021

Posted on March 26, 2021 by Luis Gil Abinader

PDF version here:LGA-NIST-Subject-Invention-definition-26March2021 More on the NIST proposed changes to the Bayh-Dole Regulations. https://www.keionline.org/35432 Comments of Luis Gil Abinader of Knowledge Ecology International on the redefinition of “Subject Invention” to Narrow the Inventions to Which Government Rights Attach (Modify 37… Continue Reading →

Negotiations on the 74th World Health Assembly (WHA) resolution on local production

Negotiating texts for WHA 74 on local production. 4 December 2020. Concept Note (Text prepared by Ethiopia) Zero Draft resolution on Strengthening Local Production of Medicines and Other Health Technologies to Improve Access, Dec 04,2020 – WHO Resolution on Strengthening… Continue Reading →

On Joe Allen’s claims that former Senators can provide authoritative statements on legislative intent decades after leaving office, especially when they worked as lobbyists

Posted on March 18, 2021 by Kathryn Ardizzone

A recent blog published in IPWatchdog expresses outrage at accurate observations made by James Love, director of Knowledge Ecology International (KEI), that former Senators Birch Bayh and Bob Dole acquired financial ties to the pharmaceutical industry between the enactment of… Continue Reading →

Categories